Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |